Literature DB >> 19649567

Reflex sympathetic dystrophy in patients with metastatic renal cell carcinoma treated with everolimus.

Christophe Massard1, Karim Fizazi, Marine Gross-Goupil, Bernard Escudier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19649567     DOI： 10.1007/s10637-009-9295-8

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN： 0167-6997            Impact factor:   3.850


× No keyword cloud information.
  4 in total

1.  Reflex sympathetic dystrophy.

Authors:  A T Marshall; A J Crisp
Journal:  Rheumatology (Oxford)       Date:  2000-07       Impact factor: 7.580

2.  Reflex sympathetic dystrophy in a renal transplant patient treated with sirolimus.

Authors:  An Vanacker; Ignace Vandewiele; Patrik Aerts; Jozef De Groof; Bart Maes
Journal:  Nephrol Dial Transplant       Date:  2007-06-16       Impact factor: 5.992

3.  Sympathetic dystrophy associated with sirolimus therapy.

Authors:  Miguel Gonzalez Molina; Fritz Diekmann; Dolores Burgos; Mercedes Cabello; Verónica Lopez; Federico Oppenheimer; Alfonso Navarro; Joseph Campistol
Journal:  Transplantation       Date:  2008-01-27       Impact factor: 4.939

4.  Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.

Authors:  Robert J Motzer; Bernard Escudier; Stéphane Oudard; Thomas E Hutson; Camillo Porta; Sergio Bracarda; Viktor Grünwald; John A Thompson; Robert A Figlin; Norbert Hollaender; Gladys Urbanowitz; William J Berg; Andrea Kay; David Lebwohl; Alain Ravaud
Journal:  Lancet       Date:  2008-07-22       Impact factor: 79.321
  4 in total
  6 in total

1.  Rapamycin Exacerbates Cardiovascular Dysfunction after Complete High-Thoracic Spinal Cord Injury.

Authors:  Khalid C Eldahan; David H Cox; Jenna L Gollihue; Samir P Patel; Alexander G Rabchevsky
Journal:  J Neurotrauma       Date:  2018-01-29       Impact factor: 5.269

Review 2.  Targeting AMPK for the Alleviation of Pathological Pain.

Authors:  Marina N Asiedu; Gregory Dussor; Theodore J Price
Journal:  Exp Suppl       Date:  2016

3.  mTORC1 inhibition induces pain via IRS-1-dependent feedback activation of ERK.

Authors:  Ohannes K Melemedjian; Arkady Khoutorsky; Robert E Sorge; Jin Yan; Marina N Asiedu; Arely Valdez; Sourav Ghosh; Gregory Dussor; Jeffrey S Mogil; Nahum Sonenberg; Theodore J Price
Journal:  Pain       Date:  2013-03-15       Impact factor: 6.961

Review 4.  Adenosine Monophosphate-activated Protein Kinase (AMPK) Activators For the Prevention, Treatment and Potential Reversal of Pathological Pain.

Authors:  Theodore J Price; Vaskar Das; Gregory Dussor
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

Review 5.  mTOR kinase: a possible pharmacological target in the management of chronic pain.

Authors:  Lucia Lisi; Paola Aceto; Pierluigi Navarra; Cinzia Dello Russo
Journal:  Biomed Res Int       Date:  2015-01-01       Impact factor: 3.411

Review 6.  Pharmacological Manipulation of Translation as a Therapeutic Target for Chronic Pain.

Authors:  Muhammad Saad Yousuf; Stephanie I Shiers; James J Sahn; Theodore J Price
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.